e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Pathophysiology of pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Vascular wall remodeling in patients with chronic thromboembolic pulmonary hypertension: a role for C-reactive protein
M. Wynants, R. Quarck, E. Alfaro-Moreno, B. Meyns, M. Delcroix (Leuven, Belgium; Mexico City, Mexico)
Source:
Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Session:
Pathophysiology of pulmonary hypertension
Session type:
E-Communication Session
Number:
293
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Wynants, R. Quarck, E. Alfaro-Moreno, B. Meyns, M. Delcroix (Leuven, Belgium; Mexico City, Mexico). Vascular wall remodeling in patients with chronic thromboembolic pulmonary hypertension: a role for C-reactive protein. Eur Respir J 2008; 32: Suppl. 52, 293
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Vascular remodeling in chronic thromboembolic pulmonary hypertension: Involvement of dedifferentiated smooth muscle cells and C-reactive protein
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension},
Source: Eur Respir J 2012; 40: 886-894
Year: 2012
Inflammatory cell accumulation in pulmonary arteries is associated with systemic inflammation in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
Chronic thromboembolic pulmonary hypertension: role of medical therapy
Source: Eur Respir J 2013; 41: 985-990
Year: 2013
Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature
Source: Eur Respir J 2014; 44: 1275-1288
Year: 2014
Platelet function in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease
Year: 2009
C reactive protein level in pulmonary embolism. A marker of inflammatory processes in chronic thromboembolic pulmonary hypertension?
Source: Eur Respir J 2007; 30: Suppl. 51, 602s
Year: 2007
C-reactive protein and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease with pulmonary arterial hypertension
Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD
Year: 2010
Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2015; 46: 431-443
Year: 2015
Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2013; 41: 224-232
Year: 2013
Involvement of the pulmonary micro-vasculature in chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Endothelial dysfunction in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Chronic thromboembolic pulmonary hypertension: animal models
Source: Eur Respir J 2013; 41: 1200-1206
Year: 2013
Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Regulation of inflammation process in chronic thromboembolic pulmonary hypertension: a potential role of platelet-activating factor-acetylhydrolase
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006
Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2009; 19: 64-67
Year: 2010
Evaluation of serum cytokines in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with hypercholesterolemia
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2012; 21: 27-31
Year: 2012
Pulmonary vascular response to exercise in heart-failure patients with pulmonary hypertension: role of a pre-capillary component
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
The impact of immediate postoperative pulmonary vascular resistance on survival in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept